Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Mouse CD74 Antibody, R&D Systems™

Sheep Polyclonal Antibody has been used in 2 publications
Supplier: R&D Systems AF7478
This item is not returnable.
View return policy
Description
CD74 Polyclonal specifically detects CD74 in Mouse samples. It is validated for Western Blot, Immunohistochemistry.Specifications
| CD74 | |
| Polyclonal | |
| Unconjugated | |
| NP_034675 | |
| CD74 | |
| Chinese hamster ovary cell line CHO-derived recombinant mouse CD74 Gln56-Leu215 Accession # NP_034675 | |
| 100 μg | |
| Primary | |
| Detects mouse CD74 in direct ELISAs and Western blots. In direct ELISAs, approximately 50% cross-reactivity with recombinant human CD74 is observed. | |
| Mouse | |
| IgG |
| Western Blot, Immunohistochemistry | |
| LYOPH | |
| Western Blot 2 ug/mL, Simple Western 20 ug/mL, Immunohistochemistry 5-15 ug/mL | |
| CD74, CD74 antigen, CD74 antigen (invariant polypeptide of major histocompatibility complex, classII antigen-associated), CD74 molecule, major histocompatibility complex, class II invariant chain, CLIP, DHLAG, DHLAGgamma chain of class II antigens, HLA class II histocompatibility antigen gamma chain, HLADG, HLA-DR antigens-associated invariant chain, HLA-DR-gamma, Ia antigen-associated invariant chain, Ia-associated invariant chain, Ia-GAMMA, Ii, INVG34, MHC HLA-DR gamma chain, p33 | |
| Sheep | |
| Antigen Affinity-purified | |
| RUO | |
| 972 | |
| Sterile PBS to a final concentration of 0.2 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction